
In this episode of The Egg Factor, Dr. Norbert Gleicher is joined by Professor Raoul Orvieto to discuss one of the most debated topics in reproductive medicine: whether preimplantation genetic testing for aneuploidy (PGT-A) improves IVF outcomes or may have unintended limitations.
They explore the science behind embryo testing, its impact on embryo selection and transfer decisions, and the challenges of interpreting genetic results. Tune in for an in-depth discussion of the evidence, controversies, and clinical considerations shaping the role of PGT-A in modern IVF.
Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.
Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.
Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.
Website: https://centerforhumanreprod.com
Facebook: https://www.facebook.com/chrnewyork
Instagram: https://www.instagram.com/chrnewyork/
Linkedin: https://www.linkedin.com/company/centerforhumanreproduction/
Pinterest: https://www.pinterest.com/CenterforHumanReproduction/
Weitere Episoden von „The Egg Factor“



Verpasse keine Episode von “The Egg Factor” und abonniere ihn in der kostenlosen GetPodcast App.








